While GoodRx Holdings Inc has underperformed by -0.46%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GDRX rose by 9.58%, with highs and lows ranging from $9.37 to $4.14, whereas the simple moving average jumped by 3.13% in the last 200 days.
On April 10, 2024, KeyBanc Capital Markets Upgraded GoodRx Holdings Inc (NASDAQ: GDRX) to Overweight. A report published by Wells Fargo on March 25, 2024, Upgraded its rating to ‘Overweight’ for GDRX. JP Morgan also Upgraded GDRX shares as ‘Overweight’, setting a target price of $10 on the company’s shares in a report dated March 01, 2024. Leerink Partners Initiated an Outperform rating on February 26, 2024, and assigned a price target of $8. BofA Securities January 02, 2024d its ‘Buy’ rating to ‘Underperform’ for GDRX, as published in its report on January 02, 2024. DA Davidson’s report from August 10, 2023 suggests a price prediction of $9.50 for GDRX shares, giving the stock a ‘Buy’ rating. TD Cowen also rated the stock as ‘Outperform’.
Analysis of GoodRx Holdings Inc (GDRX)
Further, the quarter-over-quarter increase in sales is 6.81%, showing a positive trend in the upcoming months.
GoodRx Holdings Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -1.12% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.12, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and GDRX is registering an average volume of 1.40M. On a monthly basis, the volatility of the stock is set at 4.93%, whereas on a weekly basis, it is put at 4.41%, with a loss of -3.26% over the past seven days. Furthermore, long-term investors anticipate a median target price of $8.78, showing growth from the present price of $6.52, which can serve as yet another indication of whether GDRX is worth investing in or should be passed over.
How Do You Analyze GoodRx Holdings Inc Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 80.57%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 13.28% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
GDRX shares are owned by institutional investors to the tune of 13.28% at present.
